{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:02:53Z","timestamp":1781737373611,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Otsuka Pharnma GmbH"},{"name":"Lundbeck Germany GmbH"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.schres.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T07:10:36Z","timestamp":1749798636000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Predictors of symptomatic and wellbeing remission in real-world samples of patients living with schizophrenia treated with aripiprazole once-monthly by means of constrained confidence partitioning"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5646","authenticated-orcid":false,"given":"Christoph U.","family":"Correll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Janetzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brieden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2025.06.004_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2008.09.014","article-title":"Symptom remission in first episode patients","volume":"106","author":"Addington","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2022.06.006","article-title":"Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank","volume":"246","author":"Bracher-Smith","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1137\/110832707","article-title":"On optimal weighted balanced clusterings: gravity bodies and power diagrams","volume":"26","author":"Brieden","year":"2012","journal-title":"SIAM J. Discret. Math."},{"key":"10.1016\/j.schres.2025.06.004_bb0025","article-title":"Response prediction: gaining reliable and interpretable insight from small study data","author":"Brieden","year":"2022","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2025.06.004_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.04.001","article-title":"Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance","volume":"129","author":"Brissos","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.06.004_bb0040","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00127-017-1388-7","article-title":"Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis","volume":"52","author":"Conus","year":"2017","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2025.06.004_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41537-023-00405-5","article-title":"Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly","volume":"9","author":"Correll","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"key":"10.1016\/j.schres.2025.06.004_bb0050","article-title":"Beyond symptom improvement: transdiagnostic anddisorder-specific ways to assess functional and quality of life outcomes acrossmental disorders in adults","volume":"24","author":"Correll","year":"2025","journal-title":"World Psych."},{"key":"10.1016\/j.schres.2025.06.004_bb0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.schres.2021.11.020","article-title":"New insight into the CATIE study by constrained confidence partitioning. An innovative technique towards personalized antipsychotic drug therapy in schizophrenia treatment","volume":"239","author":"Fruth","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0060","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2013"},{"key":"10.1016\/j.schres.2025.06.004_bb0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"J\u00e4\u00e4skel\u00e4inen","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2025.06.004_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115421","article-title":"Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia","volume":"328","author":"Johansson","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.schres.2025.06.004_bb0080","first-page":"1014","article-title":"Logistic regression models in obstetrics and gynecology literature","volume":"93","author":"Khan","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.schres.2025.06.004_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0090","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.4088\/JCP.v67n1104","article-title":"Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia","volume":"67","author":"Lambert","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eurpsy.2009.09.001","article-title":"Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment","volume":"25","author":"Lambert","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31887\/DCNS.2010.12.3\/mlambert","article-title":"Remission in schizophrenia: validity, frequency, predictors, and patients\u2019 perspective 5 years later","volume":"12","author":"Lambert","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.06.004_bb0105","article-title":"Personal recovery in people with a psychotic disorder: a systematic review and meta-analysis of associated factors","volume":"12","author":"Leendertse","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2025.06.004_bb0110","series-title":"Frontiers in Econometrics","first-page":"105","article-title":"Conditional logit analysis of qualitative choice behavior","author":"McFadden","year":"1974"},{"key":"10.1016\/j.schres.2025.06.004_bb0115","series-title":"Behavioural Travel Modelling . London","article-title":"Quantitative methods for analyzing travel behaviour on individuals: some recent developments","author":"McFadden","year":"1979"},{"key":"10.1016\/j.schres.2025.06.004_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12888-019-2103-x","article-title":"Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study","volume":"19","author":"Mustafa","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.schres.2015.07.007","article-title":"Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia","volume":"168","author":"Naber","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/NDT.S194264","article-title":"Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation","volume":"15","author":"Nash","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2025.06.004_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jclinepi.2003.05.003","article-title":"A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions","volume":"57","author":"Ottenbacher","year":"2004","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2025.06.004_bb0140","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.schres.2025.06.004_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/wps.20924","article-title":"The utility of patient-reported outcome measures in mental health","volume":"21","author":"Roe","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hup.1067","article-title":"Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder","volume":"24","author":"Rossi","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2025.06.004_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12888-018-1946-x","article-title":"Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study","volume":"18","author":"Sch\u00f6ttle","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0160","series-title":"Resource Use in a Non-Interventional Study on Treatment with Aripiprazole Once-Monthly","first-page":"210","author":"Sch\u00f6ttle","year":"2021"},{"key":"10.1016\/j.schres.2025.06.004_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2023.08.026","article-title":"Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly","volume":"260","author":"Sch\u00f6ttle","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.06.004_bb0170","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1038\/s41380-023-02298-3","article-title":"An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2025.06.004_bb0175","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1553-2712.2011.01185.x","article-title":"Logistic regression: a brief primer","volume":"18","author":"Stoltzfus","year":"2011","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.schres.2025.06.004_bb0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1198\/tast.2009.08210","article-title":"Coefficients of determination in logistic regression models\u2014a new proposal: the coefficient of discrimination","volume":"63","author":"Tjur","year":"2009","journal-title":"Am. Stat."},{"key":"10.1016\/j.schres.2025.06.004_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000376585","article-title":"The WHO-5 well-being index: a systematic review of the literature","volume":"84","author":"Topp","year":"2015","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2025.06.004_bb0190","article-title":"Quality of reporting of multivariable logistic regression models in Chinese clinical medical journals","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425002087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425002087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:32:26Z","timestamp":1774711946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S0920996425002087"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.06.004","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of symptomatic and wellbeing remission in real-world samples of patients living with schizophrenia treated with aripiprazole once-monthly by means of constrained confidence partitioning","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}